Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Frontiers in Immunology
|
July 20, 2023
IRF4 is required for migration of CD4<sup>+</sup> T cells to the intestine but not for Th2 and Th17 cell maintenance
Constantin Schmidt, Aenne Harberts, Daniel Reimers, et al.
BMC Cancer
|
November 23, 2020
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
Jenny Krause, Johann von Felden, Christian Casar, et al.
Journal of Hepatology
|
January 15, 2019
Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis
Tobias Schmidt, Dorothee Schwinge, Tim Rolvien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 27, 2022
Kidney-resident innate-like memory γδ T cells control chronic <i>Staphylococcus aureus</i> infection of mice
Tabea Bertram, Daniel Reimers, Niels C Lory, et al.
Annals of Hepatology
|
August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Frontiers in Immunology
|
February 8, 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Frontiers in Immunology
|
January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Annals of Hepatology
|
October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Lorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy
Joao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
Science Immunology
|
August 10, 2020
Pathogen-induced tissue-resident memory T<sub>H</sub>17 (T<sub>RM</sub>17) cells amplify autoimmune kidney disease
Christian F Krebs, Daniel Reimers, Yu Zhao, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Frontiers in Immunology
|
July 20, 2023
IRF4 is required for migration of CD4<sup>+</sup> T cells to the intestine but not for Th2 and Th17 cell maintenance
Constantin Schmidt, Aenne Harberts, Daniel Reimers, et al.
BMC Cancer
|
November 23, 2020
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
Jenny Krause, Johann von Felden, Christian Casar, et al.
Journal of Hepatology
|
January 15, 2019
Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis
Tobias Schmidt, Dorothee Schwinge, Tim Rolvien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 27, 2022
Kidney-resident innate-like memory γδ T cells control chronic <i>Staphylococcus aureus</i> infection of mice
Tabea Bertram, Daniel Reimers, Niels C Lory, et al.
Annals of Hepatology
|
August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Frontiers in Immunology
|
February 8, 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Frontiers in Immunology
|
January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Annals of Hepatology
|
October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Lorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy
Joao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
Science Immunology
|
August 10, 2020
Pathogen-induced tissue-resident memory T<sub>H</sub>17 (T<sub>RM</sub>17) cells amplify autoimmune kidney disease
Christian F Krebs, Daniel Reimers, Yu Zhao, et al.
Page
of 3